We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19 (RESPIRE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04776044
Recruitment Status : Terminated (general circumstances around COVID-19 and current availability of hospitalized patients)
First Posted : March 1, 2021
Last Update Posted : September 22, 2022
Information provided by (Responsible Party):
Atriva Therapeutics GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 6, 2022
Actual Study Completion Date : August 9, 2022